| CAS NO: | 570-63-8 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| Cas No. | 570-63-8 |
| 别名 | Β-去氧胆酸 |
| Canonical SMILES | C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(O)=O)([H])[C@@]3([H])[C@@](C[C@@H]1O)([H])[C@@]4([C@](C[C@H](CC4)O)([H])CC3)C |
| 分子式 | C24H40O4 |
| 分子量 | 392.6 |
| 溶解度 | Methanol: soluble |
| 储存条件 | -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
| 产品描述 | 3-Epideoxycholic acid (EDCA) is a secondary bile acid and an epimer of deoxycholic acid .1EDCA has been used as a steroidal host compound for the enantioselective purification of (2R,3S)-3-methyl-2-pentanol from its racematesviaenclathration.2Fecal levels of EDCA are decreased in patients with pediatric non-alcoholic fatty liver disease (NAFLD).1 1.Yu, J., Zhang, H., Chen, L., et al.Disease-associated gut microbiota reduces the profile of secondary bile acids in pediatric nonalcoholic fatty liver diseaseFront. Cell. Infect. Microbiol.11698852(2021) 2.Kato, K., Aburaya, K., Miyake, Y., et al.Excellent enantio-selective enclathration of (2R,3S)-3-methyl-2-pentanol in channel-like cavity of 3-epideoxycholic acid, interpreted by the four-location model for chiral recognitionChem. Commun. (Camb.)232872-2873(2003) |
m.cnreagent.com